At Quay Pharma, we are highly experienced in preformulation and analysis of Active Pharmaceutical Ingredients (APIs), including those that present particular challenges.
We regularly help early stage companies evaluate their new drug’s physicochemical properties, carrying out the essential groundwork for optimising the formulation and delivery method.
We can then create an appropriate product for your needs, whether you require a fit-for-purpose formulation for initial preclinical safety and efficacy testing or a formulation strategy designed to help your drug progress into clinical use.
